Lupus Research Alliance Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA
- Wednesday, July 22, 2020, 7:03
- Finance
- Add a comment
NEW YORK, July 22, 2020 /PRNewswire/ — The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA filing and priority review designation by the U.S. Food and Drug Administration for its investigational drug voclosporin for lupus nephritis. A serious…
About the Author
adminasapcorp has written 41828 stories on this site.